What is the Aldosterone-Renin Ratio (ARR) and how is it calculated?

The ARR is the primary screening test for primary aldosteronism. Formula: Plasma Aldosterone Concentration (PAC in ng/dL) divided by Plasma Renin Activity (PRA in ng/mL/hr). Cut-off: ARR above 30 with PAC above 15 ng/dL = screen-positive for PA. Example: Aldosterone 35 ng/dL / PRA 0.3 ng/mL/hr = ARR 117 (high - suggests PA). Example: Aldosterone 38 / PRA 8 = ARR 4.75 (normal - suggests secondary aldosteronism). If using Direct Renin Concentration (DRC), the formula and cut-off differ. Both aldosterone AND renin must be collected simultaneously under identical conditions.

Why does the aldosterone test need such complex preparation?

The aldosterone-renin ratio is uniquely sensitive to pre-analytical conditions: Posture (aldosterone rises 2-4x with standing - ambulatory 30+ minutes before draw is standard). Medications (spironolactone/eplerenone: stop 4-6 weeks; beta-blockers raise ARR falsely; ACE inhibitors/ARBs lower ARR falsely; amlodipine preferred as it minimally affects ARR). Potassium (hypokalaemia suppresses aldosterone even in PA - correct to above 3.5 mmol/L before testing). Sodium intake (normal diet, neither very high nor very low). Time of day (8-10 AM, morning collection). Inadequate preparation produces false-positive or false-negative ARR values that can lead to missed PA or unnecessary invasive investigation.

My potassium keeps dropping despite supplements. Could aldosterone be the cause?

Yes - persistent hypokalaemia requiring large potassium supplements to maintain normal levels is a significant clue for primary aldosteronism. Normal kidneys conserve potassium aggressively when depleted, reducing urinary excretion to as low as 20 mmol/day. If potassium keeps falling despite supplementation, the kidneys are continuing to excrete potassium - excess aldosterone is the most common hormonal cause. Measure fractional excretion of potassium or spot urine potassium-creatinine ratio to confirm urinary potassium wasting. Investigate with ARR alongside.

Aldosterone Test Explained: Normal Range, High & Low Levels, Blood Pressure & Adrenal Function (India 2026)

एल्डोस्टेरोन टेस्ट गाइड: Normal Range, Primary Aldosteronism, Aldosterone-Renin Ratio (ARR), High BP का Hidden Cause, Low Aldosterone — पूरी जानकारी

A plain-language guide for patients & families · भारतीय मरीज़ों और परिवारों के लिए सरल मार्गदर्शिका

Your blood pressure remains stubbornly elevated despite two or three antihypertensive medications, and your doctor has noticed your potassium is consistently low — and now an aldosterone test has been ordered. Or you have been diagnosed with resistant hypertension and an aldosterone-renin ratio (ARR) is part of the investigation. Or you are investigating adrenal insufficiency and need to understand why your electrolytes keep going wrong. Aldosterone is the body's primary mineralocorticoid hormone — a steroid produced by the adrenal cortex that governs sodium and potassium balance in the kidneys, and in doing so, directly controls blood pressure, blood volume, and electrolyte homeostasis. Disorders of aldosterone secretion — too much (primary aldosteronism, the most common curable cause of hypertension) or too little (adrenal insufficiency, hypoaldosteronism) — affect millions of Indians, yet remain chronically under-diagnosed because the aldosterone test and aldosterone-renin ratio are not routinely ordered in hypertension evaluation in most Indian clinical settings. This guide explains the aldosterone test completely — what it measures, the correct preparation protocol, normal ranges, how to interpret the ARR, and what elevated or suppressed aldosterone means for your health.

For related adrenal tests, see our DHEA-S guide. For electrolyte tests see our Serum Electrolytes guide. For reading lab reports generally, see our beginner's guide.

Blood pressure 2–3 antihypertensive medications के बावजूद high है, potassium consistently low है — aldosterone test order हुआ। या resistant hypertension में aldosterone-renin ratio (ARR) investigation part है। Aldosterone = body का primary mineralocorticoid hormone — adrenal cortex द्वारा produce, kidney में sodium और potassium balance govern करता है → blood pressure + blood volume + electrolyte homeostasis control। Disorders: too much (primary aldosteronism — most common curable cause of hypertension) या too little (adrenal insufficiency) → millions of Indians affect। Chronically under-diagnosed। यह guide aldosterone test completely explain करती है।

Table of Contents / विषय सूची

What Is Aldosterone? / Aldosterone क्या है?
The RAAS System — How Aldosterone Is Regulated
What the Aldosterone Test Measures
The Aldosterone-Renin Ratio (ARR) — The Most Important Test
Normal Range & Reference Values
High Aldosterone — Primary Aldosteronism & Other Causes
Low Aldosterone — Adrenal Insufficiency & Hypoaldosteronism
India Context — Hypertension, Resistant BP & Low Potassium
Test Preparation Checklist / टेस्ट की तैयारी
Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल

Aldosterone test salt water dam gatekeeper analogy India 2026 — Image 1: Understanding aldosterone — the salt-water dam and kidney gatekeeper analogy. Aldosterone acts as the kidney's gatekeeper for sodium (salt) and potassium balance. Think of the kidney tubules as a dam with two gates: the sodium gate (allowing sodium to be reclaimed from the urine back into the bloodstream) and the potassium gate (allowing potassium to be pushed from the bloodstream into the urine for excretion). Aldosterone opens the sodium gate (promoting sodium retention) and simultaneously opens the potassium gate (promoting potassium excretion). The consequences of aldosterone's actions at the dam: sodium retention → water follows sodium by osmosis → increased blood volume → raised blood pressure. Potassium loss → hypokalaemia (low blood potassium) → muscle weakness, cramps, cardiac arrhythmia risk. When aldosterone levels are correct: sodium and potassium are in balance, blood pressure is appropriate. When aldosterone is too high (primary aldosteronism): excess sodium retention → hypertension + excess potassium excretion → hypokalaemia. When aldosterone is too low (adrenal insufficiency): sodium wasting → low blood pressure, dehydration + potassium retention → hyperkalaemia (high potassium) → dangerous cardiac arrhythmia risk. This gatekeeper mechanism, operating through specific aldosterone receptors (mineralocorticoid receptors, MR) in the kidney's collecting tubules, is the physiological basis for the entire class of antihypertensive drugs called mineralocorticoid receptor antagonists (MRAs — spironolactone, eplerenone) that block aldosterone's sodium-retaining effects.

5–15% of hypertensives Primary aldosteronism (PA) — excess aldosterone from the adrenal gland independent of normal RAAS regulation — is the most common curable cause of hypertension, estimated to affect 5–15% of all hypertensive patients. In India, where hypertension affects over 220 million adults, this translates to potentially 11–33 million Indians with undiagnosed or misdiagnosed primary aldosteronism — the vast majority managed with standard antihypertensives rather than curative surgery or targeted spironolactone.

ARR is the screening test The Aldosterone-Renin Ratio (ARR) — not aldosterone alone — is the standard first-line screening test for primary aldosteronism. Aldosterone alone without renin context is uninterpretable for PA diagnosis. A high ARR (elevated aldosterone relative to suppressed renin) is the hallmark of primary aldosteronism. ARR should be measured in all patients with resistant hypertension, spontaneous hypokalaemia, or hypertension with an adrenal incidentaloma.

Curable in 35–40% Approximately 35–40% of primary aldosteronism cases are caused by a unilateral adrenal adenoma (aldosterone-producing adenoma — APA) — and these are potentially curative by laparoscopic adrenalectomy. The remaining 60–65% have bilateral adrenal hyperplasia — managed medically with mineralocorticoid receptor antagonists (spironolactone, eplerenone). Distinguishing unilateral from bilateral disease requires adrenal venous sampling (AVS) — the gold standard localisation test.

What Is Aldosterone?

Aldosterone is a steroid hormone (a mineralocorticoid) produced by the zona glomerulosa — the outermost layer of the adrenal cortex. It is the body's primary regulator of sodium and potassium balance in the distal tubules and collecting ducts of the kidney. Aldosterone binds to mineralocorticoid receptors (MR) in the principal cells of the collecting duct, triggering: increased expression of the epithelial sodium channel (ENaC) on the apical membrane (allowing more sodium to be reabsorbed from the tubular fluid into the cell); increased activity of Na+/K+-ATPase on the basolateral membrane (pumping sodium into the bloodstream while pumping potassium into the cell, from where it exits into the tubular fluid for excretion). Net effect: sodium is retained in the body, potassium is excreted, water follows sodium by osmosis (increasing blood volume), and blood pressure rises.

Aldosterone = steroid hormone (mineralocorticoid), zona glomerulosa (adrenal cortex की outermost layer) द्वारा produce। Primary regulator of Na+ और K+ balance in kidney's distal tubules + collecting ducts। Mineralocorticoid receptors (MR) से bind → ENaC expression increase (Na+ reabsorb) + Na+/K+-ATPase activity increase (Na+ bloodstream में, K+ tubular fluid में excrete)। Net effect: Na+ retain + K+ excrete + water follows (blood volume increase) + blood pressure rise।

    Aldosterone's broader physiological roles beyond blood pressure:
    Cardiovascular effects beyond blood pressure: Aldosterone has direct fibrotic and inflammatory effects on the heart and blood vessels — independent of blood pressure. Excess aldosterone promotes cardiac fibrosis, left ventricular hypertrophy, endothelial dysfunction, and inflammation of blood vessel walls. This explains why primary aldosteronism causes more cardiovascular damage (heart attacks, strokes, atrial fibrillation, heart failure) than simple essential hypertension at the same blood pressure level — the excess aldosterone itself is directly harmful to the heart and vessels.
Kidney effects: Excess aldosterone increases glomerular filtration pressure and promotes renal fibrosis over time — contributing to chronic kidney disease in patients with long-standing primary aldosteronism. Early diagnosis and treatment is associated with preservation of kidney function.
Metabolic effects: Aldosterone promotes insulin resistance (through effects on glucose transporter expression in muscle and adipose tissue) and may worsen the metabolic syndrome — an important consideration in Indian patients where insulin resistance and hypertension frequently coexist.
Mineralocorticoid receptors in other tissues: MRs are expressed not only in the kidney but also in the heart, brain, blood vessels, and colon. Aldosterone acts on these tissues to promote fibrosis and inflammation. Brain MR activation may contribute to cognitive impairment and mood disorders associated with excess aldosterone.

    Aldosterone's broader roles: Cardiovascular: direct fibrotic + inflammatory effects on heart/vessels (blood pressure independent)। Excess aldosterone → cardiac fibrosis, LVH, endothelial dysfunction। Primary aldosteronism में: same BP level पर essential hypertension से more cardiovascular damage (MI, stroke, AF, heart failure)। Kidney: glomerular filtration pressure increase + renal fibrosis → CKD। Metabolic: insulin resistance promote (glucose transporter expression affect) → metabolic syndrome worsen। India में: insulin resistance + hypertension frequently coexist। MRs: kidney, heart, brain, blood vessels, colon — fibrosis + inflammation। Brain MR: cognitive impairment + mood disorders।
  

The RAAS System — How Aldosterone Is Regulated

Aldosterone secretion is regulated primarily through the Renin-Angiotensin-Aldosterone System (RAAS) — a hormonal cascade that links kidney perfusion pressure, blood volume, and blood pressure with adrenal aldosterone secretion. Understanding the RAAS is essential for interpreting both the aldosterone test and the aldosterone-renin ratio:

Aldosterone secretion primarily = RAAS (Renin-Angiotensin-Aldosterone System) द्वारा regulate — hormonal cascade जो kidney perfusion pressure + blood volume + blood pressure को adrenal aldosterone secretion से link करती है। Aldosterone test और ARR interpret करने के लिए RAAS समझना essential है।

Normal RAAS — Negative Feedback Loop Normal RAAS — Negative Feedback Loop

The RAAS cascade: (1) When blood pressure falls, blood volume decreases, or sodium delivery to the kidney tubules decreases — the kidney's juxtaglomerular cells (JG cells) detect these signals and release renin (a proteolytic enzyme) into the bloodstream. (2) Renin cleaves the liver protein angiotensinogen to produce angiotensin I. (3) Angiotensin I is converted to angiotensin II by ACE (Angiotensin-Converting Enzyme — primarily in the lung endothelium). (4) Angiotensin II stimulates the adrenal zona glomerulosa to secrete aldosterone. (5) Aldosterone acts on the kidney to retain sodium and water — raising blood pressure and volume. (6) As blood pressure rises, the JG cells reduce renin release — the negative feedback loop that prevents excessive aldosterone secretion. The key principle for test interpretation: in normal physiology, renin and aldosterone move together — high renin appropriately stimulates high aldosterone (secondary hyperaldosteronism); low renin appropriately produces low aldosterone. The pathological pattern is high aldosterone with low renin — the hallmark of primary aldosteronism.

RAAS cascade: BP fall/volume decrease/Na+ delivery decrease → kidney JG cells → renin release। Renin + angiotensinogen → Angiotensin I। Angiotensin I + ACE (lung endothelium) → Angiotensin II। Angiotensin II → adrenal zona glomerulosa → aldosterone। Aldosterone → kidney → Na+ + water retain → BP + volume raise। BP rise → JG cells → renin release reduce (negative feedback)। Key for test: Normal physiology: renin + aldosterone together move। High renin → appropriately high aldosterone (secondary hyperaldosteronism)। Pathological pattern: HIGH ALDOSTERONE + LOW RENIN = primary aldosteronism hallmark।

Secondary Hyperaldosteronism — RAAS Appropriately Activated Secondary Hyperaldosteronism — Appropriately Activated RAAS

Secondary hyperaldosteronism is elevated aldosterone that is physiologically appropriate — the RAAS is appropriately activated in response to perceived low blood volume or low blood pressure. Both renin AND aldosterone are elevated. This represents a normal RAAS response to an abnormal underlying state:

Heart failure (reduced cardiac output → perceived low blood volume → RAAS activation)
Cirrhosis with ascites (third-spacing of fluid → low effective circulating volume → RAAS)
Nephrotic syndrome (protein loss → low oncotic pressure → fluid shifts → RAAS)
Renal artery stenosis (reduced kidney perfusion → JG cells secrete excess renin → high renin → secondary aldosteronism)
Sodium restriction or diuretic use (volume depletion → RAAS activation)
Pregnancy (normal physiological secondary aldosteronism — RAAS is upregulated)

Secondary hyperaldosteronism: elevated aldosterone = physiologically appropriate। Both renin AND aldosterone elevated। Normal RAAS response to abnormal underlying state: Heart failure (low output → perceived low volume)। Cirrhosis with ascites (third-spacing → low effective volume)। Nephrotic syndrome (protein loss → fluid shifts)। Renal artery stenosis (low kidney perfusion → excess renin → high renin secondary aldosteronism)। Sodium restriction/diuretics (volume depletion)। Pregnancy (physiological — RAAS upregulated)।

What the Aldosterone Test Measures

Test	What It Measures	Sample Type	Clinical Use
Serum Aldosterone (Plasma Aldosterone Concentration — PAC)	Circulating aldosterone level in blood — nanogram/dL or pmol/L	Blood (morning, after 30 minutes upright posture for ambulatory testing). Strict pre-analytical conditions required.	Part of the ARR calculation. Cannot be interpreted meaningfully without simultaneous renin. Never used alone for primary aldosteronism diagnosis.
Plasma Renin Activity (PRA)	The rate at which renin generates angiotensin I — ng/mL/hr	Blood (same sample as aldosterone — critical that both are collected under identical conditions)	Denominator of the ARR. Low PRA (below 1 ng/mL/hr) in context of elevated aldosterone = primary aldosteronism. PRA and direct renin concentration (DRC) are both used — the ARR formula differs depending on which renin assay is used.
Direct Renin Concentration (DRC) Active Renin Concentration	The mass concentration of renin protein in blood — mU/L or pg/mL	Blood (same conditions as aldosterone)	Modern alternative to PRA — more reproducible, less temperature-sensitive. ARR using DRC uses different numerical cut-offs than ARR using PRA. Increasingly used in Indian NABL labs. Confirm which renin assay your lab uses.
Urine Aldosterone (24-hour) Urinary Aldosterone Excretion	Total aldosterone excreted in urine over 24 hours — µg/24 hours	24-hour urine collection (with pH maintained at 4–5)	Used during confirmatory testing for primary aldosteronism (salt loading test — after 3-day high sodium intake or IV saline infusion, aldosterone fails to suppress appropriately in PA). Also used in specialised centres for Cushing syndrome workup.
Aldosterone-Renin Ratio (ARR)	Calculated ratio: Aldosterone ÷ Renin (PRA or DRC)	Derived from simultaneous blood samples	The primary screening test for primary aldosteronism. High ARR = aldosterone elevated relative to (suppressed) renin = primary aldosteronism suspected. The single most important aldosterone-related test in clinical practice.

Tests: Serum Aldosterone (PAC): circulating aldosterone, blood (morning, 30 min upright) — ARR calculation part, alone interpret नहीं। Plasma Renin Activity (PRA): ng/mL/hr — ARR denominator। Direct Renin Concentration (DRC): modern alternative to PRA, more reproducible। Urine Aldosterone 24-hour: confirmatory testing (salt loading test)। Aldosterone-Renin Ratio (ARR): Aldosterone ÷ Renin — PRIMARY SCREENING TEST for primary aldosteronism। High ARR = aldosterone elevated + renin suppressed = primary aldosteronism suspect।

The Aldosterone-Renin Ratio (ARR) — The Most Important Test

Aldosterone renin ratio ARR diagnostic matrix India 2026 — Image 2: The Aldosterone-Renin Ratio (ARR) diagnostic matrix — interpreting the four possible aldosterone-renin combinations. The ARR integrates two numbers into a single ratio that captures the pathological pattern of primary aldosteronism: aldosterone that is autonomous (secreted independently of renin stimulation) and renin that is suppressed (because the excess aldosterone provides volume expansion that signals the kidney to suppress renin production through negative feedback). The four key patterns: (1) High aldosterone + Low renin = HIGH ARR = Primary aldosteronism (aldosterone-secreting adrenal adenoma or bilateral adrenal hyperplasia) — the primary aldosteronism pattern. (2) High aldosterone + High renin = NORMAL ARR = Secondary hyperaldosteronism (heart failure, cirrhosis, renal artery stenosis — the RAAS is appropriately activated). (3) Low aldosterone + Low renin = LOW ARR = Hypoaldosteronism (adrenal insufficiency, hyporeninemic hypoaldosteronism — common in diabetic nephropathy). (4) Low aldosterone + High renin = LOW/NORMAL ARR = Bartter syndrome, pseudohypoaldosteronism, or mineralocorticoid receptor defect. The ARR cut-off: most commonly 30 (when using PAC in ng/dL and PRA in ng/mL/hr) — an ARR above 30 warrants further confirmatory testing for primary aldosteronism.

    How to calculate and interpret the ARR — with worked examples:
    ARR formula (using PRA): ARR = Plasma Aldosterone Concentration (ng/dL) ÷ Plasma Renin Activity (ng/mL/hr). Example: Aldosterone 28 ng/dL ÷ PRA 0.4 ng/mL/hr = ARR 70. This is above the standard cut-off of 30 → screen-positive for primary aldosteronism → confirmatory testing required.
ARR formula (using DRC): ARR = PAC (ng/dL) ÷ DRC (mU/L). The cut-off is different — typically 3.7 (when PAC in ng/dL and DRC in mU/L) or 2.4 (when PAC in pmol/L and DRC in mU/L). The formula and cut-off vary by the specific renin assay used — your lab report should specify.
Worked example — PRIMARY ALDOSTERONISM pattern: Aldosterone 35 ng/dL + PRA 0.3 ng/mL/hr → ARR = 35/0.3 = 117 (well above 30). Interpretation: Aldosterone is elevated AND renin is suppressed (below 1 ng/mL/hr) → this is not a RAAS-appropriate response → primary aldosteronism suspected.
Worked example — SECONDARY ALDOSTERONISM pattern: Aldosterone 38 ng/dL + PRA 8 ng/mL/hr → ARR = 38/8 = 4.75 (well below 30). Interpretation: Aldosterone is elevated AND renin is also elevated — this is an appropriately activated RAAS. Primary aldosteronism excluded. Investigate for secondary causes (heart failure, cirrhosis, renal artery stenosis).
Worked example — NORMAL: Aldosterone 12 ng/dL + PRA 1.5 ng/mL/hr → ARR = 12/1.5 = 8. Both aldosterone and renin are in normal ranges, ARR below 30 → primary aldosteronism not indicated.
Critical caveat — minimum aldosterone threshold: When PRA is very low (e.g., 0.1 ng/mL/hr), even a normal aldosterone of 10 ng/dL gives ARR = 100 — a technically "positive" ARR. Most guidelines require both a positive ARR AND an aldosterone above a minimum threshold (typically above 15 ng/dL, or in some guidelines above 6–10 ng/dL) before proceeding to confirmatory testing — to avoid false-positive ARR from low-renin states with normal aldosterone.

    ARR formula (PRA): PAC (ng/dL) ÷ PRA (ng/mL/hr)। Example: 28 ÷ 0.4 = 70 → above 30 cut-off → screen-positive → confirmatory testing। ARR formula (DRC): PAC (ng/dL) ÷ DRC (mU/L) → cut-off typically 3.7। Lab report specify करेगा। Primary aldosteronism pattern: 35 ÷ 0.3 = 117 (elevated aldosterone + suppressed renin)। Secondary aldosteronism: 38 ÷ 8 = 4.75 (elevated aldosterone + elevated renin = RAAS-appropriate)। Normal: 12 ÷ 1.5 = 8। Critical caveat: Very low PRA → ARR artificially elevated। Most guidelines require: positive ARR + aldosterone above minimum threshold (>15 ng/dL या 6–10 ng/dL) before confirmatory testing।
  

Normal Range & Reference Values

*Reference ranges for aldosterone vary significantly between assay platforms, collection conditions (supine vs upright), sodium intake, and laboratories. The values below represent approximate consensus ranges used in Indian NABL-accredited labs. Always use the reference range on your specific report. Units: Aldosterone is commonly reported in ng/dL, nmol/L, or pg/mL in India. Renin (PRA) in ng/mL/hr or µg/L/hr. DRC in mU/L.

Parameter	Normal Range (Ambulatory — Upright)	Supine (after 60 min rest)	Clinical Notes
Serum / Plasma Aldosterone (PAC)	7–30 ng/dL approximately 194–832 pmol/L	3–15 ng/dL approximately 83–416 pmol/L	Aldosterone rises 2–4× with upright posture (standing stimulates aldosterone secretion via the RAAS). Normal range differs substantially between supine and ambulatory collection. Always note collection position on the request form. Aldosterone also varies with sodium intake — high sodium suppresses, low sodium stimulates.
Plasma Renin Activity (PRA)	0.5–4.0 ng/mL/hr	0.2–2.5 ng/mL/hr	PRA below 1 ng/mL/hr in a hypertensive patient is considered low and suggestive of autonomous aldosterone secretion when combined with elevated aldosterone. PRA is technically challenging — samples must be collected in chilled tubes, processed at 4°C. PRA below 0.1 ng/mL/hr (near-undetectable) is seen in primary aldosteronism.
Direct Renin Concentration (DRC)	4–46 mU/L (ambulatory)	2–25 mU/L (supine)	More stable than PRA — does not require chilled sample processing. DRC below 5 mU/L (ambulatory) with elevated aldosterone = ARR positive. Some labs report renin in pg/mL — confirm units with your lab.
Aldosterone-Renin Ratio (ARR)	Below 30 (PAC ng/dL ÷ PRA ng/mL/hr)	ARR above 30 (using PAC in ng/dL and PRA in ng/mL/hr) = screen-positive for primary aldosteronism. If DRC used: ARR above 3.7 (ng/dL ÷ mU/L). ARR requires both PAC above minimum threshold AND suppressed renin. Cut-off varies between guidelines — always note which cut-off your reporting physician uses.
24-hour Urine Aldosterone	3–20 µg/24 hours	After high sodium loading (3 days of 6 g/day sodium diet or IV saline infusion): aldosterone should suppress to below 12 µg/24 hours in normal individuals. Failure to suppress = confirmatory evidence of primary aldosteronism.

Normal ranges: PAC ambulatory: 7–30 ng/dL। Supine: 3–15 ng/dL। Aldosterone 2–4× rise with upright posture। Sodium intake effect: high Na+ = suppress, low Na+ = stimulate। PRA ambulatory: 0.5–4.0 ng/mL/hr। Supine: 0.2–2.5। PRA <1 ng/mL/hr = low (PA suggest)। DRC ambulatory: 4–46 mU/L। ARR: below 30 = normal (PAC ng/dL ÷ PRA ng/mL/hr)। Above 30 = screen-positive। Urine aldosterone: 3–20 µg/24h। After salt loading: <12 µg/24h normally। Failure to suppress = PA confirmatory।

⚠️ Critical pre-analytical variables that affect aldosterone and ARR results — why the preparation protocol matters enormously:

Posture: Aldosterone rises 2–4-fold with standing (upright posture) compared to lying down. The ambulatory ARR (30 minutes of upright posture before blood draw) is the standard for PA screening. Supine and ambulatory reference ranges are completely different — never compare supine aldosterone to an ambulatory reference range or vice versa.
Medications that affect the ARR — and which cannot be stopped: Mineralocorticoid receptor antagonists (spironolactone, eplerenone) and potassium-sparing diuretics (amiloride, triamterene) must be stopped 4–6 weeks before aldosterone testing — they increase renin and decrease the ARR, potentially masking primary aldosteronism. Beta-blockers decrease renin (increasing the ARR — potential false-positive). ACE inhibitors and ARBs increase renin (decreasing the ARR — potential false-negative). Dihydropyridine calcium channel blockers (amlodipine, nifedipine) minimally affect the ARR and are the preferred antihypertensives to continue during aldosterone testing. If antihypertensive medications cannot be safely stopped, verapamil (slow-release) and hydralazine are the least ARR-disruptive alternatives. All medication status must be clearly documented on the test request form.
Hypokalaemia: Low potassium suppresses aldosterone secretion even in primary aldosteronism — a normal or mildly elevated aldosterone in the context of hypokalaemia may actually be inappropriately elevated relative to the potassium suppression. Potassium should ideally be corrected to normal (above 3.5 mmol/L) before aldosterone testing for the most accurate results.
Time of day: Aldosterone has mild diurnal variation (higher in the morning). Ambulatory testing should be performed between 8–10 AM after the patient has been up and moving for at least 30 minutes.

Critical pre-analytical variables: Posture: Aldosterone 2–4× rise with standing। Ambulatory (30 min upright) = standard for PA screening। Supine vs ambulatory ranges completely different। Medications: Spironolactone/eplerenone: stop 4–6 weeks before (renin increase → ARR decrease → false-negative PA)। Beta-blockers: renin decrease → ARR increase → false-positive PA। ACE inhibitors/ARBs: renin increase → ARR decrease → false-negative। Preferred to continue: dihydropyridine CCBs (amlodipine) — least ARR-disruptive। Hypokalaemia: aldosterone secretion suppress → correct K+ to >3.5 mmol/L before testing। Time of day: 8–10 AM (30 min upright)।

High Aldosterone — Primary Aldosteronism & Other Causes

Primary Aldosteronism (PA) — The Most Common Curable Hypertension Primary Aldosteronism — Most Common Curable Hypertension

Primary aldosteronism (PA, also called Conn syndrome when due to a unilateral adenoma) is the autonomous over-production of aldosterone from one or both adrenal glands — independent of renin stimulation. The hallmark: elevated aldosterone + suppressed renin = high ARR. PA is the most common form of secondary (identifiable-cause) hypertension and the most common curable form. In India, where hypertension affects 220+ million adults and most are managed empirically with antihypertensives without investigation of secondary causes, PA is dramatically under-diagnosed. Key clinical features that should trigger investigation:

Hypertension resistant to three or more antihypertensives (including a diuretic) at adequate doses
Spontaneous hypokalaemia (low potassium without diuretics) — potassium below 3.5 mmol/L
Hypokalaemia induced by a low dose of diuretic (thiazide, loop diuretic)
Hypertension with adrenal incidentaloma (adrenal tumour found incidentally on CT/MRI)
Hypertension with a family history of PA or hypertension with early-onset stroke (<40 years)
Hypertension with atrial fibrillation unexplained by other causes
Severely elevated blood pressure (above 160/100) at a young age (<40)

Primary aldosteronism (PA / Conn syndrome): autonomous aldosterone over-production। Elevated aldosterone + suppressed renin = high ARR। Most common secondary hypertension + most common curable form। India में: 220+ million hypertensives में dramatically under-diagnosed। Investigation triggers: Resistant HTN (3+ antihypertensives at adequate doses)। Spontaneous hypokalaemia (<3.5 mmol/L, without diuretics)। Low-dose diuretic-induced hypokalaemia। HTN + adrenal incidentaloma। Family history PA या early stroke (<40 years)। HTN + AF (unexplained)। Severely elevated BP (>160/100) at young age (<40)।

Diagnostic Pathway for Primary Aldosteronism in India India में Primary Aldosteronism Diagnostic Pathway

The step-by-step evaluation after an elevated ARR:

Step 1 — Screening: ARR (ambulatory morning sample, correct medication preparation). ARR above 30 (PAC/PRA) with PAC above 15 ng/dL = screen-positive.
Step 2 — Confirmatory testing: One of four tests to confirm autonomous aldosterone secretion: (a) Oral sodium loading — 3 days of 6g/day sodium diet; 24-hour urine aldosterone above 12 µg on day 3 = confirmed PA. (b) Saline infusion test — 2 litres IV normal saline over 4 hours; aldosterone above 10 ng/dL at end of infusion = confirmed PA. (c) Fludrocortisone suppression test (FST). (d) Captopril challenge test (CCT) — widely used in India as it is simple and safe; aldosterone fails to suppress appropriately after 25–50 mg captopril in PA.
Step 3 — CT scan of adrenals: After confirmed PA — adrenal CT to look for an adrenal adenoma or mass. CT is NOT adequate alone for lateralisation — a CT-negative PA still requires AVS.
Step 4 — Adrenal Venous Sampling (AVS): The gold standard for distinguishing unilateral (adenoma — potentially curable by surgery) from bilateral (hyperplasia — managed medically) PA. AVS catheterises both adrenal veins and selectively measures aldosterone and cortisol. Available at select major Indian centres (AIIMS Delhi, PGI Chandigarh, CMC Vellore, major private tertiary hospitals).
Step 5 — Treatment: Unilateral APA → laparoscopic adrenalectomy (potentially curative). Bilateral adrenal hyperplasia → lifelong mineralocorticoid receptor antagonist (spironolactone 12.5–50 mg/day, or eplerenone).

PA diagnostic pathway: Step 1 — Screening: ARR ambulatory (correct medication preparation)। ARR >30 + PAC >15 ng/dL = screen-positive। Step 2 — Confirmatory: Oral sodium loading (6g/day 3 days, urine aldosterone >12 µg)। Saline infusion test (2L IV NS 4 hours, aldosterone >10 ng/dL)। Captopril challenge test (CCT — widely used India, simple + safe)। Step 3 — Adrenal CT (adenoma/mass look for)। CT alone lateralisation के लिए NOT adequate। Step 4 — Adrenal Venous Sampling (AVS): gold standard (AIIMS, PGI, CMC Vellore)। Step 5 — Treatment: Unilateral APA → laparoscopic adrenalectomy। Bilateral hyperplasia → spironolactone/eplerenone lifelong।

Secondary Hyperaldosteronism — High Aldosterone, High Renin Secondary Hyperaldosteronism — High Both

When both aldosterone AND renin are elevated, the ARR is normal or low — indicating secondary (appropriate, RAAS-driven) aldosterone excess. The causes:

Heart failure: Reduced cardiac output → perceived low blood volume → RAAS activation → high renin + high aldosterone. Treatment with ACE inhibitors/ARBs/spironolactone targets this pathway (hence the benefit of spironolactone in heart failure — blocking the harmful aldosterone effects on the heart even when aldosterone elevation is secondary).
Renal artery stenosis: Reduced kidney perfusion → very high renin → very high aldosterone → severe hypertension. A renovascular cause of hypertension — diagnosed by Doppler ultrasound or CT angiography of renal arteries, treated by angioplasty/stenting.
Cirrhosis with ascites: Third-spacing → low effective blood volume → high renin + high aldosterone. Spironolactone is the first-line diuretic for cirrhotic ascites — it blocks the harmful aldosterone-mediated sodium retention.
Bartter syndrome and Gitelman syndrome: Rare genetic tubular disorders causing salt wasting → very high renin + high aldosterone + hypokalaemia. Distinguished from PA by the very high renin (low in PA).

Secondary hyperaldosteronism: Both aldosterone AND renin elevated → ARR normal/low। Causes: Heart failure (low output → RAAS → high renin + aldosterone → spironolactone beneficial even though secondary)। Renal artery stenosis (low kidney perfusion → very high renin → severe HTN, Doppler/CTA diagnose, angioplasty treat)। Cirrhosis ascites (third-spacing → high renin + aldosterone → spironolactone first-line diuretic)। Bartter/Gitelman syndrome (genetic salt wasting → very high renin → from PA by high renin distinguished)।

Low Aldosterone — Adrenal Insufficiency & Hypoaldosteronism

    Causes of low aldosterone and their clinical consequences:
    Primary adrenal insufficiency (Addison's disease): Destruction of the entire adrenal cortex destroys all three zones — zona glomerulosa (aldosterone), zona fasciculata (cortisol), and zona reticularis (DHEA-S). All three hormones are deficient. Aldosterone deficiency → sodium loss → volume depletion → low blood pressure, dehydration + potassium retention → hyperkalaemia → dangerous cardiac arrhythmia risk. In India, TB adrenalitis (tuberculosis infection of the adrenal glands) is an important cause — India's high TB burden makes TB adrenalitis a significant clinical entity that is often missed. Autoimmune Addison's (the most common cause in Western countries) is less well-characterised in India but is diagnosed. Clinical: fatigue, weight loss, hyperpigmentation (skin darkening — from elevated ACTH stimulating melanocortin receptors, only in primary adrenal insufficiency), salt craving, postural hypotension, nausea. Emergency: adrenal crisis — volume collapse, severe hypotension, vomiting, abdominal pain → life-threatening without immediate IV hydrocortisone and fluid replacement.
Secondary adrenal insufficiency: Pituitary disease (reduced ACTH) → adrenal atrophy → reduced cortisol AND DHEA-S. However, aldosterone is RELATIVELY PRESERVED in secondary adrenal insufficiency — because aldosterone is primarily regulated by the RAAS (renin/angiotensin) rather than ACTH. This is an important clinical distinction: secondary adrenal insufficiency causes cortisol deficiency but usually NOT severe aldosterone deficiency — which is why it does not typically present with hyperkalaemia or salt craving (features of mineralocorticoid deficiency).
Hyporeninemic hypoaldosteronism (Type IV renal tubular acidosis): A form of aldosterone deficiency caused by low renin — seen particularly in patients with diabetic nephropathy (the kidney's juxtaglomerular apparatus is damaged by diabetic nephropathy → reduced renin production → reduced aldosterone). Also seen in: NSAIDs (suppress renin), beta-blockers (suppress renin), calcineurin inhibitors (cyclosporin, tacrolimus — post-transplant). Clinical: hyperkalaemia (often disproportionate to degree of kidney disease), metabolic acidosis, relatively normal blood pressure. Very common in Indian diabetic patients — often first noticed as unexplained persistent hyperkalaemia in a diabetic patient with mild-to-moderate CKD.
Mineralocorticoid receptor blockers (iatrogenic hypoaldosteronism effects): Spironolactone, eplerenone — these block the mineralocorticoid receptor, producing the physiological consequences of aldosterone deficiency (sodium loss, potassium retention, low blood pressure) even though aldosterone levels are often elevated (because blocking the MR increases renin and aldosterone production through feedback). Serum potassium must be monitored carefully in all patients on spironolactone or eplerenone.

    Low aldosterone causes: Primary adrenal insufficiency (Addison's): all three zones destroy → aldosterone + cortisol + DHEA-S deficient। Aldosterone deficiency → Na+ loss → volume depletion → low BP + K+ retention → hyperkalaemia → cardiac arrhythmia। India में: TB adrenalitis important cause (often missed)। Autoimmune Addison's भी। Hyperpigmentation (primary में only — elevated ACTH)। Adrenal crisis = emergency (IV hydrocortisone + fluids)। Secondary adrenal insufficiency: ACTH low → cortisol + DHEA-S low। Aldosterone RELATIVELY PRESERVED (RAAS regulate करती है, ACTH नहीं)। No severe hyperkalaemia/salt craving। Hyporeninemic hypoaldosteronism (Type IV RTA): diabetic nephropathy में JG apparatus damage → low renin → low aldosterone। NSAIDs/beta-blockers/calcineurin inhibitors। Clinical: hyperkalaemia, metabolic acidosis। Common in Indian diabetic patients। Mineralocorticoid receptor blockers (spironolactone, eplerenone): MR block → aldosterone deficiency effects (Na+ loss, K+ retention) — K+ monitor carefully।
  

India Context — Hypertension, Resistant BP & Low Potassium

The Missed Diagnosis — Primary Aldosteronism in India Missed Diagnosis — India में Primary Aldosteronism

India has one of the world's fastest-growing hypertension burdens — estimated 220 million Indians have hypertension. Despite this, the evaluation of secondary hypertension (including primary aldosteronism) is not routine in Indian clinical practice. The majority of hypertensive Indians receive empirical antihypertensive therapy without investigation for identifiable and potentially curable causes. Key reasons why PA is under-diagnosed in India:

The ARR is not routinely ordered in hypertension evaluation at primary and secondary care level — most general practitioners and internists do not screen for PA unless hypokalaemia is overt
Hypokalaemia is often absent in PA — estimated 60–70% of PA patients have normal potassium (previously thought to be a near-universal feature, now known to be present only in severe PA). Absence of hypokalaemia does not exclude PA.
The aldosterone test and ARR are not included in standard hypertension "panels" at most Indian labs — they must be specifically requested
Awareness of PA among non-specialist physicians in India remains relatively low
The high cost and specialist access requirements for confirmatory testing (saline infusion, AVS) limit complete evaluation

The clinical consequence: millions of Indians with PA are treated with generic antihypertensive combinations — with poor blood pressure control, progressive cardiovascular and renal damage from excess aldosterone — when a curative adrenalectomy or targeted spironolactone therapy would dramatically improve outcomes.

India में PA under-diagnosis reasons: ARR primary/secondary care में routine नहीं। Most GPs hypokalaemia overt न होने पर screen नहीं करते। Hypokalaemia 60–70% PA patients में ABSENT (previously thought universal — wrong)। Aldosterone test standard panels में नहीं — specifically request करना। Non-specialist awareness low। Confirmatory testing + AVS cost + specialist access। Clinical consequence: Millions PA patients generic antihypertensives पर — poor BP control, progressive CV + renal damage — जब curative adrenalectomy या targeted spironolactone dramatically better outcomes देता।

When to Suspect PA in the Indian Hypertensive Patient Indian Hypertensive Patient में PA कब Suspect करें

A practical checklist for Indian physicians and patients to recognise the clinical scenarios that warrant aldosterone-renin testing:

Blood pressure above 150/100 mmHg on three or more antihypertensive medications
Serum potassium consistently below 3.5 mmol/L, particularly if not on diuretics
Potassium below 3.0 mmol/L on a thiazide at standard dose
CT or MRI abdomen showing an adrenal nodule or mass (adrenal incidentaloma) in a hypertensive patient
Young patient (below 40 years) with significant hypertension, especially with family history of PA or early stroke/MI in relatives
Hypertension with paroxysmal episodes of headache, palpitations (to exclude phaeochromocytoma — investigate with plasma metanephrines simultaneously)
Hypertension with unexplained atrial fibrillation, particularly in patients under 60
Hypertension with nocturnal enuresis or excessive thirst/urination (these can be features of hypokalaemia from PA)
Post-kidney transplant hypertension — PA may be identified during transplant evaluation

PA suspect checklist India में: BP >150/100 on 3+ antihypertensives। K+ consistently <3.5 mmol/L (especially not on diuretics)। K+ <3.0 on standard thiazide dose। CT/MRI adrenal nodule/mass in hypertensive। Young (<40) with significant HTN + family history PA/early stroke/MI। Hypertension + paroxysmal headache/palpitations (phaeochromocytoma exclude — plasma metanephrines simultaneously)। HTN + unexplained AF (<60 years)। Hypertension + nocturnal enuresis/excessive thirst/urination (hypokalaemia features)। Post-kidney transplant HTN।

Test Preparation Checklist / टेस्ट की तैयारी

Aldosterone test preparation rules medication posture India 2026 — Image 3: Aldosterone test preparation — the most complex pre-analytical protocol of any routine clinical chemistry test. The aldosterone and ARR result is uniquely sensitive to preparation conditions — posture, medications, potassium status, sodium intake, and time of day can all substantially alter the result, producing false-positive or false-negative ARR values. Unlike most blood tests where a simple overnight fast is sufficient, the aldosterone test requires a structured pre-test protocol that may take several weeks to implement correctly (primarily because some medications must be withdrawn for 4–6 weeks). The consequence of inadequate preparation: spironolactone taken up to the day of testing can mask primary aldosteronism (increasing renin, decreasing the ARR, producing a false-negative result); a beta-blocker taken on the morning of testing can artificially suppress renin (increasing the ARR, producing a false-positive result). The Endocrine Society and European Society of Hypertension guidelines are clear: the aldosterone-renin ratio is only interpretable when collected under standardised conditions. At major Indian centres (AIIMS, PGI, JIPMER, Apollo, Kokilaben, Manipal), the first-trimester screening clinic and endocrine outpatient departments have structured aldosterone protocols — seek a centre with established expertise for the most reliable results.

✓
Medication protocol — discuss with your physician at least 4–6 weeks before the planned test date: Spironolactone and eplerenone (MR antagonists): MUST stop 4–6 weeks before testing — these are the most important medications to stop. Amiloride, triamterene (K-sparing diuretics): stop 4–6 weeks. Liquorice root supplements or candies: stop 4 weeks (glycyrrhizinic acid in liquorice has mineralocorticoid-like effects). Beta-blockers (metoprolol, atenolol, propranolol): ideally stop 2 weeks if safely possible — they suppress renin, increasing ARR falsely. ACE inhibitors, ARBs (enalapril, losartan): ideally stop 2 weeks — they increase renin, decreasing ARR potentially masking PA. Dihydropyridine calcium channel blockers (amlodipine, nifedipine): CAN BE CONTINUED — they have minimal ARR effect and are the preferred antihypertensives to maintain during testing. NSAIDs: stop 2 weeks if possible (suppress renin). NEVER stop antihypertensive medications without discussing with your physician — severe rebound hypertension can occur.
Medication protocol — physician से test से 4–6 weeks पहले discuss: Spironolactone/eplerenone: 4–6 weeks STOP। Amiloride/triamterene: 4–6 weeks stop। Liquorice supplements: 4 weeks stop। Beta-blockers: ideally 2 weeks stop (renin suppress → ARR falsely increase)। ACE inhibitors/ARBs: ideally 2 weeks stop (renin increase → ARR decrease → PA mask)। Dihydropyridine CCBs (amlodipine): CAN CONTINUE — minimal ARR effect, preferred। NSAIDs: 2 weeks stop। NEVER antihypertensives without physician discussion — rebound HTN।
✓
Posture protocol — must be followed on the day of testing: The blood sample must be collected after the patient has been ambulatory (upright, moving around) for at least 30 minutes — not immediately after lying down or sleeping. Wake up normally, move around for 30+ minutes (morning routine — showering, dressing, light activity), then sit for 5–15 minutes in the phlebotomy chair before the blood draw. The patient should NOT have been lying down immediately before the draw — even 5 minutes of lying down before the draw substantially lowers aldosterone and raises renin, confounding the result. Document posture on the request form.
Posture protocol — test के day: Blood sample: ambulatory (upright) के 30+ minutes बाद। Wake up normally → 30+ minutes move around (morning routine) → 5–15 minutes phlebotomy chair में sit → blood draw। Blood draw से immediately पहले lying down नहीं — even 5 minutes lying = aldosterone lower + renin raise → result confound। Request form पर posture document।
✓
Correct potassium before testing if hypokalaemia is present. Low potassium (hypokalaemia) suppresses aldosterone secretion, even in primary aldosteronism — producing a falsely normal or lower aldosterone that underestimates the true degree of excess. Before aldosterone testing, potassium should be repleted to normal (above 3.5 mmol/L, ideally 4.0 mmol/L or above) using oral potassium chloride supplements (not IV unless urgent). A normal potassium before testing maximises the sensitivity of the ARR for detecting PA. Confirm serum potassium (electrolytes panel) at the same time as aldosterone testing.
Hypokalaemia correct करें before testing। Low K+ → aldosterone secretion suppress (even in PA) → falsely normal/lower aldosterone → PA underestimate। Before aldosterone testing: K+ replete to >3.5 mmol/L (ideally ≥4.0)। Oral KCl supplements। Testing के same time serum potassium (electrolytes panel) confirm।
✓
Sodium intake — maintain normal diet (neither very high nor very low sodium) for at least 2 weeks before testing. A very low sodium diet (less than 2g/day) dramatically stimulates the RAAS — raising renin and aldosterone — potentially masking an elevated ARR. Very high sodium intake suppresses aldosterone. Eat a normal Indian diet in the 2 weeks before testing. Avoid: very salty processed foods, papad, pickle, pickled vegetables, salty crackers, and sodium-laden junk food in the days before testing. Also avoid very low-salt diets. Normal Indian home-cooked food (approximately 3–5g sodium/day) is appropriate.
Sodium intake: test से 2 weeks पहले normal diet (neither very high nor very low sodium)। Very low sodium diet (<2g/day) → RAAS dramatically stimulate → renin + aldosterone raise → elevated ARR mask। Very high sodium: aldosterone suppress। Normal Indian home-cooked food (~3–5g sodium/day) = appropriate। Avoid: papad, pickle, pickled vegetables, salty crackers, sodium-laden junk food।
✓
Timing — blood draw should be between 8–10 AM. Aldosterone has mild diurnal variation — highest in the morning. Morning sampling provides the highest aldosterone levels and the most sensitive ARR. All major aldosterone testing protocols specify morning collection. Do not collect aldosterone samples in the afternoon or evening for PA screening — these will systematically underestimate aldosterone and reduce the sensitivity of the test.
Timing: blood draw 8–10 AM। Aldosterone mild diurnal variation — morning में highest। Morning sampling = highest aldosterone + most sensitive ARR। All major protocols specify morning। Afternoon/evening collection: aldosterone systematically underestimate → sensitivity reduce।
✓
Request both aldosterone AND renin in the same blood draw — the ARR cannot be calculated without both. An aldosterone result without a simultaneously collected renin is clinically uninterpretable for primary aldosteronism diagnosis. Always ensure both tests are requested on the same form, both samples are collected at the same time and under the same conditions, and both results appear on the same report. Note which renin assay the lab uses (PRA or DRC) — this determines which ARR cut-off applies.
Both aldosterone AND renin same blood draw में request करें। Aldosterone without simultaneously collected renin = PA diagnosis के लिए clinically uninterpretable। Both tests same form पर। Same time + same conditions collect। Same report पर both results। Renin assay note: PRA (ng/mL/hr) या DRC (mU/L) — ARR cut-off determine करता है।

✅ Book Aldosterone + Renin (ARR) Test — NABL Labs

Always book aldosterone AND renin together (simultaneously) for the ARR calculation. Collect 8–10 AM, ambulatory (30+ minutes upright before draw), normal sodium diet 2 weeks before, correct potassium to above 3.5 mmol/L before testing. Stop spironolactone/eplerenone 4–6 weeks before. Add serum electrolytes (sodium, potassium) to the same draw:

Aldosterone (PAC) + Plasma Renin Activity (PRA) or Direct Renin Concentration (DRC) + Serum Electrolytes (Na, K) 8–10 AM collection · 30+ minutes ambulatory before draw · Normal sodium diet 2 weeks before · Potassium corrected >3.5 mmol/L · Stop spironolactone/eplerenone 4–6 weeks before · Document all medications on request form · NABL-accredited endocrine lab · Digital report with ARR calculation · Available at major Indian reference labs

Book Aldosterone + Renin (ARR) →

Affiliate link: I may earn a small commission at no extra cost to you. Aldosterone and renin testing is available at government medical college hospitals and major NABL reference labs. Always have ARR results interpreted by a qualified endocrinologist or nephrologist alongside clinical history, medication list, potassium level, blood pressure records, and adrenal imaging where indicated. Never start or stop antihypertensive medications based on test results without physician guidance.

Aldosterone + renin साथ book। 8–10 AM, 30+ min ambulatory। Normal Na+ diet 2 weeks। K+ correct (>3.5)। Spironolactone/eplerenone 4–6 weeks stop। Medications document। Endocrinologist/nephrologist से ARR + clinical history + medications + K+ + BP records + adrenal imaging interpret। Antihypertensives start/stop physician guidance के बिना नहीं।

Blood Pressure Monitoring & Electrolyte Support

Two products directly relevant to aldosterone-related conditions — an accurate home blood pressure monitor (essential for any patient being evaluated or treated for primary aldosteronism, where detailed blood pressure tracking before and after treatment is needed, and for patients with hypoaldosteronism-related low blood pressure monitoring) and an electrolyte supplement (aldosterone directly regulates sodium and potassium balance; patients with primary aldosteronism typically have sodium excess and potassium depletion; patients with adrenal insufficiency have sodium depletion and potassium excess — electrolyte support is relevant in both contexts under physician guidance). These products support monitoring and recovery — they are not treatments for primary aldosteronism, adrenal insufficiency, or hypertension. Blood pressure management and aldosterone-related conditions require physician prescription and monitoring. Do not self-medicate electrolytes without physician guidance — potassium supplementation in patients with hypoaldosteronism or on ACE inhibitors/ARBs/spironolactone can cause dangerous hyperkalaemia.

Dr. Morepen Blood Pressure Monitor — Model BP-02

Home blood pressure monitoring (HBPM) is a clinically important component of the evaluation and management of aldosterone-related hypertension for three specific reasons. First, for baseline documentation before treatment: when primary aldosteronism is suspected, multiple blood pressure readings over 1–2 weeks at different times of day and in different postures (lying, sitting, standing — orthostatic blood pressure) provide the clinical context for interpreting the aldosterone result and assessing the response to treatment. PA characteristically causes non-dipping hypertension — blood pressure remains elevated even during night-time sleep (the normal nocturnal "dip" of 10–20% is absent in PA) — home monitors with data logging can capture the pattern of readings that help characterise this. Second, for monitoring treatment response: in patients treated for PA with either adrenalectomy or spironolactone, blood pressure response is the primary outcome measure. A successful adrenalectomy for unilateral APA reduces or cures hypertension in approximately 35–72% of patients over 6–12 months. Detailed home BP tracking (morning, evening, weekly averages) documents this response, guides antihypertensive medication tapering, and detects residual hypertension that may require ongoing pharmacological management. Third, for patients with hypoaldosteronism and adrenal insufficiency: these patients typically have low blood pressure, orthostatic hypotension (dizziness on standing from BP drop), and are prone to dehydration-related hypotensive episodes. Regular home BP monitoring helps them and their physicians calibrate fludrocortisone (aldosterone replacement) dosing and hydrocortisone doses, and detect adrenal insufficiency decompensation early. The Dr. Morepen BP-02 provides upper-arm cuff measurement (clinically superior to wrist-cuff monitors for accuracy — particularly important in patients with significant hypertension or hypotension where accurate readings are critical for clinical decisions), automatic inflation, digital reading, and data storage. Blood pressure monitors are monitoring tools — they do not treat hypertension or aldosterone disorders. Always share home BP logs with your treating physician at every appointment. Do not adjust antihypertensive medications based on home readings without physician guidance.

Home BP monitoring: 3 specific clinical reasons। 1. Baseline documentation before treatment: multiple readings (lying, sitting, standing — orthostatic BP)। PA: non-dipping hypertension (nocturnal dip absent) — data logging capture। 2. Treatment response monitor: Adrenalectomy (unilateral APA) → 35–72% cure/reduce। Morning + evening home BP (weekly averages) → response document, antihypertensives taper guide। 3. Hypoaldosteronism/adrenal insufficiency: low BP, orthostatic hypotension, dehydration → fludrocortisone + hydrocortisone dosing calibrate। Dr. Morepen BP-02: upper-arm cuff (wrist-cuff से clinically superior — accuracy important for significant HTN/hypotension)। Automatic inflation, digital, data storage। Monitoring tool — BP treat नहीं। Home BP logs = physician को every appointment share। View on Amazon India

Affiliate link — small commission at no extra cost.

Supply6 Salts Electrolyte Mix — Zero Added Sugar, Sodium & Potassium

Aldosterone is the body's primary regulator of sodium and potassium homeostasis — making electrolyte management directly relevant to virtually all clinical presentations of aldosterone dysregulation. The clinical electrolyte implications by condition: In primary aldosteronism, excess aldosterone causes chronic sodium retention (expanding blood volume, raising blood pressure) and potassium depletion (causing hypokalaemia — muscle cramps, weakness, constipation, fatigue, and in severe cases cardiac arrhythmia). The treatment of PA with spironolactone or adrenalectomy corrects this — but during the investigative phase and while awaiting treatment, potassium supplementation (oral KCl) is commonly required to correct hypokalaemia that has accumulated from aldosterone-driven urinary potassium losses. In adrenal insufficiency (Addison's disease, hypoaldosteronism), the opposite pattern occurs: sodium is lost in the urine while potassium accumulates. These patients need adequate sodium replacement (through normal dietary salt intake and in some cases fludrocortisone, the synthetic aldosterone replacement, which promotes sodium retention) and must avoid excessive potassium intake. The Supply6 Salts electrolyte formulation provides a balanced mix of sodium, potassium, magnesium, and chloride in a zero-added-sugar, hydration-optimised format. It is particularly relevant for: patients recovering from potassium depletion in PA (where oral KCl supplementation is required alongside aldosterone testing and treatment); patients with adrenal insufficiency who need reliable sodium and electrolyte replenishment, particularly during illness (when the risk of adrenal crisis is highest and the body's requirement for sodium replacement is greatest); patients with hyporeninemic hypoaldosteronism or Type IV RTA who require careful electrolyte monitoring; and for general rehydration in hot Indian climates where significant sodium and potassium are lost through sweating. CRITICAL WARNING: Do NOT take potassium-containing electrolyte supplements if you are on ACE inhibitors, ARBs, or spironolactone without physician advice — these medications already tend to elevate potassium, and adding extra potassium can cause life-threatening hyperkalaemia (dangerously high potassium). Similarly, do not use high-potassium electrolyte supplements if you have adrenal insufficiency with hyperkalaemia, Type IV RTA, or chronic kidney disease — where potassium retention is already a problem. Always check your serum electrolytes (sodium and potassium) with your physician before starting any electrolyte supplement regimen.

Aldosterone = primary Na+ और K+ homeostasis regulator। Clinical implications by condition: Primary aldosteronism: Na+ retention + K+ depletion (hypokalaemia — cramps, weakness, fatigue, cardiac arrhythmia)। Spironolactone/adrenalectomy से correct। Investigative phase + treatment awaiting: oral KCl (potassium supplementation) commonly required। Adrenal insufficiency: opposite — Na+ loss + K+ accumulate। Adequate Na+ replacement (dietary salt + fludrocortisone)। Supply6 Salts: Na+ + K+ + Mg + Cl, zero-added-sugar, hydration-optimised। Relevant for: PA में K+ depletion recovery, adrenal insufficiency Na+ replenishment (illness में particularly — adrenal crisis risk highest), hyporeninemic hypoaldosteronism, hot Indian climate sweating। CRITICAL WARNING: ACE inhibitors/ARBs/spironolactone पर potassium supplements = NO without physician — life-threatening hyperkalaemia। Adrenal insufficiency hyperkalaemia/Type IV RTA/CKD = high-potassium supplements NO। Serum electrolytes check physician से → phir supplement। View on Amazon India

Affiliate link — small commission at no extra cost.

Related Tests / संबंधित जांचें

These tests are commonly ordered alongside aldosterone-renin testing for complete adrenal and hypertension evaluation:

Aldosterone-renin testing के साथ ये जांचें complete adrenal और hypertension evaluation में order होती हैं:

Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल

My aldosterone is elevated but my potassium is normal. Does this mean I don't have primary aldosteronism?

No — a normal potassium does not exclude primary aldosteronism. This is one of the most important misconceptions in PA diagnosis. The historical teaching was that PA typically presented with hypokalaemia (low potassium) — because the original description by Conn in 1955 described patients with severe, symptomatic PA with obvious hypokalaemia. However, large-scale prospective studies of hypertensive patients (particularly the PAPY study in Italy and subsequent international studies) found that 60–70% of PA patients have normal serum potassium at the time of diagnosis — hypokalaemia is only present in the more severe cases. The mechanism: in PA, aldosterone drives potassium into the urine. However, the body has compensatory mechanisms that can maintain serum potassium within the normal range for a substantial period — including increased dietary potassium intake and other renal compensatory mechanisms. Only when aldosterone excess is severe or chronic, or when dietary potassium intake is low, does hypokalaemia become overt. The clinical implication: the absence of hypokalaemia should never reassure a clinician or patient that PA has been excluded. If there are other features (resistant hypertension, elevated ARR, adrenal incidentaloma), investigation should proceed regardless of potassium status.

उत्तर: नहीं — Normal potassium = primary aldosteronism exclude नहीं। Most important misconception। Large-scale studies (PAPY study): 60–70% PA patients में normal serum potassium at diagnosis। Hypokalaemia = only in more severe cases। Mechanism: Aldosterone K+ urine में drive करता है, लेकिन compensatory mechanisms (dietary K+ intake, renal compensation) K+ normal range maintain कर सकते हैं। Severe/chronic excess या low dietary K+ → overt hypokalaemia। Clinical implication: Normal K+ = PA exclude नहीं। Other features (resistant HTN, elevated ARR, adrenal incidentaloma) हैं → investigation regardless of K+।

What is the difference between primary and secondary aldosteronism?

Primary aldosteronism (PA) is excess aldosterone that is produced autonomously by the adrenal gland — independently of the RAAS (renin-angiotensin system). The aldosterone production is driven by the adrenal gland itself (by an adenoma or bilateral hyperplasia), NOT by appropriate renin stimulation. In PA: aldosterone is high AND renin is suppressed (because the excess sodium retention from autonomous aldosterone signals the kidney to suppress renin through negative feedback). The ARR is therefore high. Secondary aldosteronism is excess aldosterone that is produced in response to RAAS activation — the aldosterone elevation is the physiological response to appropriate renin stimulation. Both aldosterone AND renin are elevated. The ARR is therefore normal or low. Secondary aldosteronism occurs when the RAAS is appropriately activated by: low blood volume (heart failure, cirrhosis, nephrotic syndrome, dehydration), low kidney perfusion (renal artery stenosis), or low sodium delivery to the kidney (sodium restriction, diuretics). The distinction matters enormously for treatment: primary aldosteronism requires targeted treatment (adrenalectomy or MR antagonist); secondary aldosteronism requires treatment of the underlying cause (heart failure treatment, renal artery stenting, etc.).

उत्तर: Primary aldosteronism (PA): adrenal gland से autonomous aldosterone — RAAS independent। Adrenal adenoma या bilateral hyperplasia driven। PA में: aldosterone high + renin suppressed (negative feedback से)। ARR = high। Secondary aldosteronism: RAAS activation के response में aldosterone excess — physiological। Both aldosterone AND renin elevated। ARR = normal/low। Causes: low blood volume (heart failure, cirrhosis, nephrotic, dehydration), low kidney perfusion (renal artery stenosis), low Na+ delivery (restriction, diuretics)। Treatment distinction crucial: PA → adrenalectomy या MR antagonist। Secondary → underlying cause treat।

I am on spironolactone for heart failure. Can I still get the aldosterone test?

Technically yes, but the result will be unreliable for primary aldosteronism diagnosis. Spironolactone (and eplerenone) are mineralocorticoid receptor antagonists — they block aldosterone's receptor in the kidney, producing a physiological state resembling aldosterone deficiency (sodium loss, potassium retention, low blood pressure from volume depletion). This causes secondary RAAS activation: the kidney responds to perceived volume depletion by increasing renin secretion, and the pituitary signals the adrenal gland to produce more aldosterone. On spironolactone: renin will be elevated (from volume depletion stimulus), and aldosterone will often be elevated (from secondary RAAS stimulation) — making the ARR appear falsely normal or low. This can mask primary aldosteronism entirely. For accurate PA screening, spironolactone must be stopped for 4–6 weeks before testing. However, in heart failure patients on spironolactone, stopping the drug for 4–6 weeks carries real clinical risk — heart failure may decompensate. This creates a genuine clinical dilemma that should be discussed with the cardiologist and endocrinologist. If the clinical suspicion for PA is very high in a heart failure patient on spironolactone, specialist evaluation at a combined cardiology-endocrine clinic is the appropriate pathway.

उत्तर: Technically yes, but result = unreliable for PA diagnosis। Spironolactone = MR antagonist → physiological aldosterone deficiency mimic (Na+ loss, K+ retention, volume depletion)। Secondary RAAS activation: renin elevated + aldosterone elevated → ARR falsely normal/low। PA mask entirely। Accurate PA screening: 4–6 weeks stop। Heart failure में 4–6 weeks stop = real clinical risk (decompensation)। Genuine clinical dilemma → cardiologist + endocrinologist discuss। Very high PA suspicion in HF on spironolactone → combined cardiology-endocrine clinic।

What happens after primary aldosteronism is confirmed? Is it curable?

After primary aldosteronism is confirmed by a positive ARR and a positive confirmatory test (saline infusion test or captopril challenge), the next step is subtype classification — determining whether the PA is caused by a unilateral adrenal adenoma (potentially curable) or bilateral adrenal hyperplasia (medically managed). Adrenal CT is performed, but CT alone cannot reliably distinguish unilateral from bilateral disease — adrenal venous sampling (AVS) is the gold standard for lateralisation. If AVS confirms unilateral disease (a single adrenal gland producing the excess aldosterone): laparoscopic adrenalectomy (surgical removal of the affected adrenal gland) is the treatment. Outcomes: approximately 35–72% of patients have complete cure of hypertension (blood pressure normalises without antihypertensives); the remainder have improved blood pressure (requiring fewer antihypertensives or lower doses). All patients have biochemical cure (aldosterone normalises). Kidney function often improves. Cardiovascular risk reduces toward that of patients with essential hypertension. If AVS confirms bilateral disease (both adrenal glands produce excess aldosterone): surgery is not appropriate. Lifelong medical treatment with mineralocorticoid receptor antagonists — spironolactone (25–400 mg/day, titrated to normalise potassium and blood pressure) or eplerenone (more expensive, fewer side effects — particularly fewer anti-androgenic effects relevant to young men in India who experience gynecomastia on spironolactone). Blood pressure, potassium, and kidney function require regular monitoring on these medications.

उत्तर: PA confirmed → subtype classification: Unilateral adenoma (potentially curable) vs Bilateral hyperplasia (medically managed)। Adrenal CT → Adrenal Venous Sampling (AVS) — gold standard lateralisation। Unilateral (AVS confirm): Laparoscopic adrenalectomy। Outcomes: 35–72% = complete HTN cure (no antihypertensives)। Remainder: improved BP (fewer/lower medications)। All: biochemical cure (aldosterone normalise)। Kidney function often improve। CV risk reduce। Bilateral (both adrenals): Surgery नहीं। Lifelong MR antagonist: Spironolactone (25–400 mg/day) या eplerenone (more expensive, fewer anti-androgenic effects — young Indian men में gynecomastia spironolactone पर)। BP + K+ + kidney function regular monitoring।

My potassium keeps dropping despite supplements. Could this be related to aldosterone?

Yes — persistent or recurrent hypokalaemia (low potassium) that does not correct adequately with oral potassium supplements, or that requires very large doses of supplementation to maintain a normal potassium level, is a significant clinical clue for primary aldosteronism. Normal kidneys in a healthy person retain potassium very effectively — they can reduce urinary potassium excretion to as low as 20 mmol/day when the body is potassium-depleted. If your potassium keeps falling despite adequate supplementation, your kidneys are continuing to excrete potassium in the urine — and excess aldosterone is the most common hormonal cause of this urinary potassium wasting. Other causes of urinary potassium wasting (sometimes called hypokalaemic salt-losing nephropathies) include: Bartter syndrome and Gitelman syndrome (rare genetic tubular disorders — distinguished from PA by very high renin); vomiting (with metabolic alkalosis); diuretic use (thiazides, loop diuretics — check all medications); magnesium deficiency (hypomagnesaemia — correct magnesium first, as magnesium deficiency independently causes urinary potassium wasting). The key investigation: measure the fractional excretion of potassium or a spot urine potassium-creatinine ratio — a high urinary potassium in the context of low serum potassium indicates that the kidneys are wasting potassium (not conserving it appropriately). This, alongside the ARR, guides the evaluation. Discuss with your endocrinologist or nephrologist.

उत्तर: हाँ — persistent/recurrent hypokalaemia (supplements के बावजूद या large doses required) = PA का significant clinical clue। Normal kidneys K+ deficiency में urinary K+ 20 mmol/day तक reduce। Supplements के बावजूद K+ falling = kidneys K+ urine में excrete continue — excess aldosterone = most common hormonal cause। Other causes urinary K+ wasting: Bartter/Gitelman syndrome (rare genetic, very high renin)। Vomiting (metabolic alkalosis)। Diuretics (thiazides, loop)। Magnesium deficiency (hypomagnesaemia — independent urinary K+ wasting)। Key investigation: fractional excretion of K+ या spot urine K+-creatinine ratio — high urinary K+ + low serum K+ = kidneys wasting। ARR के साथ evaluation guide। Endocrinologist/nephrologist से discuss।

External References / बाहरी संसाधन

Endocrine Society — Clinical Practice Guideline on Primary Aldosteronism: Endocrine Society — Primary Aldosteronism: Case Detection, Diagnosis, and Treatment
European Society of Hypertension — PA Guidelines: ESH — Hypertension Guidelines including Secondary Hypertension Evaluation
MedlinePlus (NIH) — Aldosterone Test: Aldosterone Test — Patient Information

⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण

This article is for educational purposes only. Aldosterone and ARR results must be interpreted by a qualified endocrinologist, nephrologist, or hypertension specialist alongside full medication history (especially spironolactone, ACE inhibitors, ARBs, beta-blockers), posture at collection, serum potassium, sodium intake, and blood pressure records. A positive ARR requires confirmatory testing before any diagnosis of primary aldosteronism is established — never start or stop medications based on an ARR result alone. Adrenal venous sampling for PA subtyping should be performed only at centres with established expertise. Never self-supplement with potassium if you are on ACE inhibitors, ARBs, or spironolactone without physician monitoring — hyperkalaemia can be life-threatening. Adrenal crisis in known adrenal insufficiency is a medical emergency requiring immediate IV hydrocortisone — ensure all adrenal insufficiency patients have an emergency injection kit and sick-day rules.

यह लेख केवल शैक्षिक उद्देश्यों के लिए है। Aldosterone + ARR को endocrinologist/nephrologist से medications + posture + K+ + Na+ intake + BP records के साथ interpret। Positive ARR → confirmatory testing पहले (PA diagnose = ARR alone enough नहीं)। Never medications start/stop based on ARR alone। AVS: established expertise centres पर only। ACE inhibitors/ARBs/spironolactone पर potassium self-supplement नहीं — hyperkalaemia life-threatening। Adrenal insufficiency में adrenal crisis = MEDICAL EMERGENCY — immediate IV hydrocortisone। Emergency injection kit + sick-day rules ensure करें।

Share on WhatsApp

Search This Blog

Blood Test Guide India | Normal Ranges, Reports & Meanings